Skip to Content

93 7212 (Metformin ER 750 mg)

Pill imprint 93 7212 has been identified as Metformin hydrochloride extended release 750 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not a controlled substance under the Controlled Substance Act (CSA).

Metformin hydrochloride extended release 750 mg 93 7212
Metformin hydrochloride extended release 750 mg 93 7212 Front
Metformin hydrochloride extended release 750 mg 93 7212 Back
Metformin hydrochloride extended release 750 mg 93 7212
Metformin hydrochloride extended release 750 mg 93 7212
Metformin hydrochloride extended release
Imprint:
93 7212
Strength:
750 mg
Color:
Red
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7212
Inactive Ingredients:
ethylcellulose (7 mPa.s)
hypromellose 2208 (100000 mPa.s)
magnesium stearate
microcrystalline cellulose
ferric oxide red
ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide